Basket

  Untick selected:   0
  1. Favorable safety profile of ixekizumab: results from 11 moderate-to-severe psoriasis and 3 psoriatic arthritis clinical trials  / Gottlieb A. ... [et al.] .  Dermatológia pre prax. - ISSN 1337-1746 . - Roč. 12, č. 3 (2018), s. 147  
    C 3084
    article

    article


  This site uses cookies to make them easier to browse. Learn more about how we use cookies.